Ronald Melki

Active 1987–2025

120
Papers
19,303
Citations
76
h-index
112
i10-index

Citations

Citations per year for Ronald Melki1971: 1 citations1988: 3 citations1989: 7 citations1990: 14 citations1991: 15 citations1992: 7 citations1993: 15 citations1994: 33 citations1995: 22 citations1996: 26 citations1997: 42 citations1998: 54 citations1999: 73 citations2000: 74 citations2001: 61 citations2002: 57 citations2003: 54 citations2004: 90 citations2005: 47 citations2006: 38 citations2007: 52 citations2008: 44 citations2009: 49 citations2010: 64 citations2011: 102 citations2012: 94 citations2013: 147 citations2014: 187 citations2015: 261 citations2016: 279 citations2017: 351 citations2018: 325 citations2019: 893 citations2020: 1,009 citations2021: 1,107 citations2022: 1,007 citations2023: 670 citations2024: 948 citations2025: 543 citations2026: 8 citations1972–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,228 citing papers, 25.3% of this breakdownChina: 745 citing papers, 8.5% of this breakdownUnited Kingdom: 735 citing papers, 8.3% of this breakdownGermany: 644 citing papers, 7.3% of this breakdownFrance: 488 citing papers, 5.5% of this breakdownItaly: 338 citing papers, 3.8% of this breakdownCanada: 293 citing papers, 3.3% of this breakdownJapan: 273 citing papers, 3.1% of this breakdownSweden: 242 citing papers, 2.7% of this breakdownSwitzerland: 220 citing papers, 2.5% of this breakdownSpain: 207 citing papers, 2.4% of this breakdownIndia: 202 citing papers, 2.3% of this breakdown
0%25.3%Other 25%

Fields

  • Medicine49.8%
  • Biochemistry, Genetics and Molecular Biology34.4%
  • Neuroscience10.9%
  • Immunology and Microbiology1%
  • Materials Science0.8%
  • Environmental Science0.7%
  • Other2.4%

Topics

  • Parkinson's Disease Mechanisms and Treatments13.2%
  • Alzheimer's disease research and treatments8.9%
  • Neurological disorders and treatments4.2%
  • Neuroinflammation and Neurodegeneration Mechanisms3.3%
  • Neurological diseases and metabolism2.7%
  • Prion Diseases and Protein Misfolding2.6%
  • Other65.1%

Coauthors

All papers

Open in search
  1. Microglia jointly degrade fibrillar alpha-synuclein cargo by distribution through tunneling nanotubes

    Authors: , , , , , , , , , , , , , , - Cell 2021 cited by 355

  2. Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats

    Authors: , , , , , , , , , - Acta Neuropathologica 2014 cited by 910

  3. α-Synuclein strains cause distinct synucleinopathies after local and systemic administration

    Authors: , , , , , , , , - Nature 2015 cited by 1,145

  4. Structural and functional characterization of two alpha-synuclein strains

    Authors: , , , , , , , , , , - Nature Communications 2013 cited by 930

  5. Two new polymorphic structures of human full-length alpha-synuclein fibrils solved by cryo-electron microscopy

    Authors: , , , , , , , , , , , , , , , - eLife 2019 cited by 351

  6. Tunneling nanotubes spread fibrillar α‐synuclein by intercellular trafficking of lysosomes

    Authors: , , , , , , , , - The EMBO Journal 2016 cited by 394

  7. Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Neuron 2024 cited by 171

  8. The structural differences between patient-derived α-synuclein strains dictate characteristics of Parkinson’s disease, multiple system atrophy and dementia with Lewy bodies

    Authors: , , , , , , , , , - Acta Neuropathologica 2020 cited by 292

  9. α‐synuclein oligomers and fibrils: a spectrum of species, a spectrum of toxicities

    Authors: , , , - Journal of Neurochemistry 2019 cited by 307

  10. G51D α‐synuclein mutation causes a novel Parkinsonian–pyramidal syndrome

    Authors: , , , , , , , , , , , , - Annals of Neurology 2013 cited by 723

  11. α-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading

    Authors: , , , , , , - Acta Neuropathologica 2017 cited by 271

  12. Increased Immune Activation by Pathologic α‐Synuclein in Parkinson's Disease

    Authors: , , , , , , , , , , , , , , - Annals of Neurology 2019 cited by 162

  13. Tunneling nanotube (TNT)-mediated neuron-to neuron transfer of pathological Tau protein assemblies

    Authors: , , , , , , , - Acta Neuropathologica Communications 2016 cited by 297

  14. Microglial NLRP3 Inflammasome Activation upon TLR2 and TLR5 Ligation by Distinct α-Synuclein Assemblies

    Authors: , , , , , , - The Journal of Immunology 2021 cited by 121

  15. LRRK2 modifies α-syn pathology and spread in mouse models and human neurons

    Authors: , , , , , , , , , , , , - Acta Neuropathologica 2019 cited by 193

  16. Disassembly of Tau fibrils by the human Hsp70 disaggregation machinery generates small seeding-competent species

    Authors: , , , , , , , , , , , , - Journal of Biological Chemistry 2020 cited by 168

  17. α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells

    Authors: , , , , , , , , , , , - Journal of Clinical Investigation 2011 cited by 837

  18. Endocytic vesicle rupture is a conserved mechanism of cellular invasion by amyloid proteins

    Authors: , , , , , , , , - Acta Neuropathologica 2017 cited by 266

  19. Intranasal administration of α-synuclein preformed fibrils triggers microglial iron deposition in the substantia nigra of Macaca fascicularis

    Authors: , , , , , , , , , , , , - Cell Death and Disease 2021 cited by 71

  20. Prion-like transmission of protein aggregates in neurodegenerative diseases

    Authors: , , - Nature Reviews Molecular Cell Biology 2010 cited by 755

  21. Alpha‐synuclein transfers from neurons to oligodendrocytes

    Authors: , , , , , - Glia 2013 cited by 275

  22. Alpha-synuclein research: defining strategic moves in the battle against Parkinson’s disease

    Authors: , , , , , , , , , , , , , , , , , , , - npj Parkinson s Disease 2021 cited by 178

  23. LAG3 is not expressed in human and murine neurons and does not modulate α‐synucleinopathies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - EMBO Molecular Medicine 2021 cited by 79

  24. Propagation of α-Synuclein Strains within Human Reconstructed Neuronal Network

    Authors: , , , , , , , - Stem Cell Reports 2019 cited by 148